Inverness Counsel’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$356K Buy
9,720
+1,310
+16% +$58.3K 0.02% 145
2022
Q2
$358K Hold
8,410
0.02% 134
2022
Q1
$452K Sell
8,410
-10,690
-56% -$622K 0.02% 132
2021
Q4
$1.37M Sell
19,100
-6,530
-25% -$409K 0.05% 75
2021
Q3
$1.46M Buy
25,630
+10,230
+66% +$622K 0.05% 75
2021
Q2
$1M Buy
15,400
+10,330
+204% +$652K 0.04% 89
2021
Q1
$302K Buy
5,070
+70
+1% +$3.81K 0.01% 127
2020
Q4
$236K Buy
+5,000
New +$210K 0.01% 132

Other funds holding LRCX

Inverness Counsel's LRCX Position: Q3 2022 in Review

Inverness Counsel increased its Lam Research (LRCX) stake by 16% in Q3 2022, buying an estimated $58.3K and bringing the position to 9,720 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #145.

Inverness Counsel first reported a position in LRCX in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.46M in Q3 2021. 1,272 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • Inverness Counsel held 9,720 shares of Lam Research worth $356K as of Q3 2022.
  • Inverness Counsel bought 1,310 Lam Research shares in Q3 2022, an estimated $58.3K.
  • Lam Research made up 0.02% of Inverness Counsel's portfolio in Q3 2022, its #145 holding.
  • Inverness Counsel first reported a position in Lam Research in Q4 2020 and has held it in 8 quarters since.
  • Inverness Counsel's Lam Research position peaked at $1.46M in Q3 2021.
  • 1,272 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.